Provider
QP95-24 Commercial Pharmacy Benefit Exclusion for lanreotide, Ultomiris® and Visudyne®
Program effective Date: Dec 23, 2024
Documents & Forms Results
Displaying 1361 - 1370 of 3585 results
Legal & Regulatory
Notice-of-Privacy-Practices-F7676R15.pdf
Legal & Regulatory
Notice-of-Privacy-Practices-F7676R15.pdf
Legal & Regulatory
HIPAA Notice of Privacy Practices
Health & Wellbeing
2025 Preventive Prenatal Benefits
Health & Wellbeing
2025 Detailed Description of Preventive Services
Provider
QP86-24 Provider Press: Q4 2024
Program effective Date: Dec 11, 2024
Provider
QP87-24 MHCP Pharmacy Benefit Exclusion for Aurlumyn™, MydCombi™, paclitaxel protein-bound particles, Pavblu™ and Vyloy®
Program effective Date: Dec 11, 2024
Provider
QP88-24 Commercial Pharmacy Benefit Exclusion for Aurlumyn™, MydCombi™, Pavblu™ and Vafseo®
Program effective Date: Dec 11, 2024